Erlotinib hydrochloride: an anticancer agent
In the cation of the title compound, C22H24N3O4+·Cl−, an active ingredient of the anticancer drug also known as Tarceva, the quinazoline ring system is planar within 0.044 (3) Å. The dihedral angle formed by the mean planes of the two six-membered quin...
Main Authors: | K. Ravikumar, B. Sridhar, S. Selvanayagam |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union of Crystallography
2008-05-01
|
Series: | Acta Crystallographica Section E |
Online Access: | http://scripts.iucr.org/cgi-bin/paper?S1600536808011707 |
Similar Items
-
Modified Synthesis of Erlotinib Hydrochloride
by: Leila Barghi, et al.
Published: (2012-06-01) -
Spectrofluorimetric Method for the Estimation of Erlotinib Hydrochloride in Pure and Pharmaceutical Formulations
by: V. Rajesh, et al.
Published: (2011-01-01) -
Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib.
by: Chun-Zhi Ai, et al.
Published: (2017-01-01) -
Darifenacin hydrobromide
by: S. Selvanayagam, et al.
Published: (2009-06-01) -
Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
by: Tan W, et al.
Published: (2011-08-01)